Megan M. Tu

Megan M. Tu

Auto-generated profile, based on publicly available information

Megan M. Tu

McMaster University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2023 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
LCLindsey A. Carfrae
Lindsey A. Carfrae
KRKenneth Rachwalski
Kenneth Rachwalski
SFShawn French
Shawn French
RGRodion Gordzevich
Rodion Gordzevich
LSLaura Seidel
Laura Seidel
EBEric D. Brown
Eric D. Brown

23 March 2022 in ACS Infectious Diseases
Verified
Journal Article
Closed access
CMCraig R MacNair
Craig R MacNair
MFMaya A. Farha
Maya A. Farha
MSMichael H. Serrano-Wu
Michael H. Serrano-Wu
KLKatie K. Lee
Katie K. Lee
BHBrian Hubbard
Brian Hubbard
EBEric D. Brown
Eric D. Brown

2 January 2025 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
MTMegan M. Tu
Megan M. Tu
LCLindsey A. Carfrae
Lindsey A. Carfrae
KRKenneth Rachwalski
Kenneth Rachwalski
SFShawn French
Shawn French
DCDenise Catacutan
Denise Catacutan
EBEric D. Brown
Eric D. Brown

3 October 2025 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
DCDenise B. Catacutan
Denise B. Catacutan
VTVian Tran
Vian Tran
AAAutumn Arnold
Autumn Arnold
JAJeremie Alexander
Jeremie Alexander
GCGabriele Corso
Gabriele Corso
JSJonathan M. Stokes
Jonathan M. Stokes

6 August 2025 in ACS Infectious Diseases
Verified
Journal Article
Closed access
AGAlexa L. Gilberti
Alexa L. Gilberti
MTMegan M. Tu
Megan M. Tu
KRKenneth Rachwalski
Kenneth Rachwalski
MAMadeeha I. Ali
Madeeha I. Ali
SCSiobhan A. Cohen
Siobhan A. Cohen
PTPeter J. Tonge
Peter J. Tonge

17 May 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
KSKyle Swanson
Kyle Swanson
GLGary Liu
Gary Liu
DCDenise B. Catacutan
Denise B. Catacutan
SMStewart McLellan
Stewart McLellan
AAAutumn Arnold
Autumn Arnold
JSJonathan M. Stokes
Jonathan M. Stokes
The rise of antibiotic-resistant pathogens such as Staphylococcus aureus has created an urgent need for new antibiotics. Generative artificial intelligence (AI) has shown promise in drug discovery, but existing models often fail to propose compounds that are both effective and synthetically tractable. To address these challenges, we introduce SyntheMol-RL, a reinforcement learning-based generative model that can rapidly design synthetically accessible small molecule drug candidates from a massive chemical space of 46 billion compounds. SyntheMol-RL improves upon our prior Monte Carlo Tree Search (MCTS)-based SyntheMol model by generalizing across chemically similar building blocks and enabling multi-parameter optimization. We applied SyntheMol-RL to generate candidate antibiotics against S. aureus by optimizing for both antibacterial activity and aqueous solubility, and we found that SyntheMol-RL generated molecules with improved predicted properties compared to both the previous MCTS version of SyntheMol as well as an AI-based virtual screening baseline. We synthesized 79 SyntheMol-RL compounds that were unique relative to the training dataset and found that 13 showed potent in vitro activity, of which seven were structurally novel after detailed literature searches. Furthermore, one hit compound, synthecin, demonstrated efficacy in a murine wound infection model of methicillin-resistant S. aureus (MRSA). These results validate SyntheMol-RL’s ability to generate novel and synthetically accessible candidate antibiotics and position SyntheMol-RL as a powerful tool for drug design across therapeutic domains.